A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma

Nima Nassiri1, Marissa Maas1, Giovanni Cacciamani2

  • 1USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Artificial Intelligence Center at USC Urology, USC Institute of Urology, University of Southern California, Los Angeles, CA, USA.

European Urology Focus
|September 20, 2021
PubMed
Summary

Radiomic analysis using machine learning can accurately differentiate benign from malignant renal masses, potentially improving patient selection for active surveillance and reducing unnecessary surgeries.

Related Concept Videos